New drug SRK-439 tested for safety in healthy adults
NCT ID NCT07444294
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 1 trial is testing the safety and tolerability of a new drug called SRK-439 in 76 healthy adults aged 18 to 55. Participants receive either a single or multiple doses of the drug or a placebo by injection. The study measures side effects, lab tests, and how the drug moves through the body. It is an early step to see if the drug is safe enough for future studies in patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SRK-439
- What could go wrong
- This is a very early Phase 1 study in healthy people, so it won't show if the drug works for any disease. The main goal is safety, not treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Medpace CPU
RECRUITINGCincinnati, Ohio, 45227, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test